Viegas Márcio, Cândido Cristina, Felgueiras Joana, Clemente José, Barros Sara, Farbota Rostislav, Vera Filipa, Matos Antero, Sousa Francisco
Hemodialysis Unit, Nephrocare, Montijo, Montijo, Portugal.
Department of Nephrology, Centro Hospitalar de, Setúbal, Setúbal, Portugal.
Hemodial Int. 2017 Jul;21(3):385-392. doi: 10.1111/hdi.12502. Epub 2016 Oct 20.
The dialysate bicarbonate (DB) influences the acid-base balance in dialysis patients. Very low and high serum bicarbonate (SB) have been related with a higher mortality. Acid-base balance also has been associated with hemodynamic effects in these patients. The trial aim was to compare the effect of DB concentration variation on SB levels in maintenance hemodiafiltration (HDF) patients and the effect on intradialytic hypotension and interdialytic weight gain.
A prospective study, with 9 months of follow-up, involving 93 patients, divided in two groups: group 1 and group 2 with a DB of 34 mmol/L and 30 mmol/L, respectively, with monitoring of pre and post HDF SB, intradialytic hypotension, and interdialytic weight gain.
Pre dialysis SB was higher in group 1: median concentration of 22.7 mmol/L vs. 21.1 mmol/L (P < 0.001). Post dialysis SB levels were higher in group 1: median concentration of 28.0 mmol/L vs. 25.3 mmol/L (P < 0.001). Post dialysis SB in alkalotic range was only detected in group 1 (51.2% of the patients). No significant differences were detected in intradialytic hypotension rate [28.0 vs. 27.4 episodes per 1000 sessions in group 1 and 2, respectively, (P = 0.906)] or in average interdialytic weight gain [2.9% vs. 3.0% in group 1 and 2, respectively, (P = 0.710)].
DB of 30 mmol/L appears to be associated with SB levels closer to physiological levels than 34 mmol/L. The bicarbonate dialysate, in the tested concentrations, did not appear to have a significant impact on intradialytic hypotension and interdialytic weight gain in maintenance HDF patients.
透析液碳酸氢盐(DB)会影响透析患者的酸碱平衡。血清碳酸氢盐(SB)水平极低和极高均与较高的死亡率相关。酸碱平衡还与这些患者的血流动力学效应有关。该试验的目的是比较DB浓度变化对维持性血液透析滤过(HDF)患者SB水平的影响,以及对透析中低血压和透析间期体重增加的影响。
一项前瞻性研究,随访9个月,纳入93例患者,分为两组:第1组和第2组,DB分别为34 mmol/L和30 mmol/L,监测HDF前后的SB、透析中低血压和透析间期体重增加情况。
第1组透析前SB较高:中位数浓度为22.7 mmol/L,而第2组为21.1 mmol/L(P<0.001)。第1组透析后SB水平较高:中位数浓度为28.0 mmol/L,而第2组为25.3 mmol/L(P<0.001)。仅在第1组中检测到透析后SB处于碱中毒范围(占患者的51.2%)。在透析中低血压发生率方面未检测到显著差异[第1组和第2组分别为每1000次透析28.0次和27.4次,(P = 0.906)],在平均透析间期体重增加方面也未检测到显著差异[第1组和第2组分别为2.9%和3.0%,(P = 0.710)]。
30 mmol/L的DB似乎比34 mmol/L更能使SB水平接近生理水平。在所测试的浓度下,碳酸氢盐透析液似乎对维持性HDF患者的透析中低血压和透析间期体重增加没有显著影响。